Daniel Markowitz Analyst PerformanceVice President at EvercoreDaniel Markowitz is a stock analyst at Evercore focused in the medical sector, covering 10 publicly traded companies. Over the past year, Daniel Markowitz has issued 28 stock ratings, including strong buy, buy, and hold recommendations. While full access to Daniel Markowitz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniel Markowitz's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings31 Last 1 YearsBuy Recommendations80.77% 21 Buy RatingsCompanies Covered10 Unique Companies Ratings Distribution26RatingsDistribution of strong buy, buy, hold, and sell ratings by Daniel Markowitz.RatingPercentageCount Strong Buy3.8%1 ratings Buy76.9%20 ratings Hold19.2%5 ratings Sell0.0%0 ratingsOut of 26 total stock ratings issued by Daniel Markowitz at Evercore, the majority (76.9%) have been Buy recommendations, followed by 19.2% Hold and 3.8% Strong Buy.Best & Worst CallsBest Call00.0%WSTMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TECHMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ80.0% of companies on NASDAQ8 companiesNYSE20.0% of companies on NYSE2 companiesDaniel Markowitz, an analyst at Evercore, currently covers 10 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical9 companies90.0%Computer and Technology1 company10.0%Daniel Markowitz of Evercore specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE3 companies30.0%MED INSTRUMENTS2 companies20.0%MEDICAL INFO SYS1 company10.0%MED PRODUCTS1 company10.0%MED/DENTAL - SUPP1 company10.0%ELEC COMP - SEMIC1 company10.0%MEDICAL SERVICES1 company10.0% Daniel Markowitz's Ratings History at Evercore Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTECHBio-Techne5/7/2026Set Price Target$48.56$50.00$0.0000.00% ROIINSPInspire Medical Systems2/27/2026Reiterated Rating$64.49Outperform$0.0000.00% ROIGHGuardant Health2/20/2026Set Price Target$106.24$110.00$0.0000.00% ROIPODDInsulet2/19/2026Set Price Target$246.42$340.00$0.0000.00% ROITECHBio-Techne2/5/2026Boost Price Target$67.44$68.00In-Line$0.0000.00% ROIWSTWest Pharmaceutical Services2/3/2026Lower Price Target$237.29$320.00Outperform$0.0000.00% ROIRMBSRambus2/3/2026Lower Price Target$113.71$119.00Outperform$0.0000.00% ROIINSPInspire Medical Systems1/22/2026Reiterated Rating$80.81$125.00Outperform$0.0000.00% ROITECHBio-Techne1/5/2026Set Price Target$59.65$62.00In-Line$0.0000.00% ROITECHBio-Techne1/5/2026Downgrade$63.03$62.00Hold$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. PODDInsulet12/16/2025Initiated Coverage$291.51$370.00Outperform$0.0000.00% ROIDXCMDexCom11/25/2025Initiated Coverage$62.21$68.00In-Line$0.0000.00% ROINTRANatera11/7/2025Boost Price Target$191.43$250.00Outperform$0.0000.00% ROITECHBio-Techne11/6/2025Set Price Target$58.40$68.00$0.0000.00% ROIGHGuardant Health10/30/2025Boost Price Target$93.49$90.00Outperform$0.0000.00% ROIRMBSRambus10/28/2025Boost Price Target$113.61$126.00Outperform$0.0000.00% ROIWSTWest Pharmaceutical Services10/23/2025Boost Price Target$308.79$390.00Outperform$0.0000.00% ROIWSTWest Pharmaceutical Services10/7/2025Set Price Target$269.32$350.00$0.0000.00% ROIGHGuardant Health10/7/2025Boost Price Target$62.55$68.00Outperform$0.0000.00% ROIRGENRepligen10/7/2025Boost Price Target$144.44$175.00Outperform$0.0000.00% ROIINSPInspire Medical Systems10/7/2025Lower Price Target$76.85$125.00Outperform$0.0000.00% ROITECHBio-Techne10/7/2025Boost Price Target$59.50$72.00Outperform$0.0000.00% ROIRGENRepligen9/22/2025Upgrade$122.30$155.00Outperform$0.0000.00% ROIRMBSRambus9/16/2025Boost Price Target$98.22$114.00Outperform$0.0000.00% ROITMDXTransMedics Group9/16/2025Initiated Coverage$114.29$155.00Outperform$0.0000.00% ROIINSPInspire Medical Systems9/2/2025Initiated Coverage$93.86$150.00Outperform$0.0000.00% ROINTRANatera7/28/2025Upgrade$138.90$170.00Strong-Buy$0.0000.00% ROIWSTWest Pharmaceutical Services7/25/2025Boost Price Target$262.83$350.00Outperform$0.0000.00% ROITECHBio-Techne3/18/2025Initiated Coverage$62.58$75.00Outperform$00.0000.00% ROIRGENRepligen3/18/2025Initiated Coverage$152.81$155.00In-Line$000.0000.00% ROIWSTWest Pharmaceutical Services3/18/2025Initiated Coverage$231.60$275.00Outperform$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
